Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 7.381
Filter
1.
Internet resource in Portuguese | LIS -Health Information Locator | ID: lis-49605

ABSTRACT

Diante do recente registro de dois casos isolados de febre amarela na região da divisa de São Paulo com Minas Gerais, o Ministério da Saúde emitiu neste domingo (28) um alerta para intensificação das ações de vigilância e imunização nas áreas com transmissão ativa do vírus da febre.


Subject(s)
Public Health Surveillance , Yellow Fever Vaccine
3.
NEJM Evid ; 3(5): EVIDra2300271, 2024 May.
Article in English | MEDLINE | ID: mdl-38815175

ABSTRACT

AbstractAccurate diagnostics are critical in public health to ensure successful disease tracking, prevention, and control. Many of the same characteristics are desirable for diagnostic procedures in both medicine and public health: for example, low cost, high speed, low invasiveness, ease of use and interpretation, day-to-day consistency, and high accuracy. This review lays out five principles that are salient when the goal of diagnosis is to improve the overall health of a population rather than that of a particular patient, and it applies them in two important use cases: pandemic infectious disease and antimicrobial resistance.


Subject(s)
Communicable Diseases , Public Health , Humans , Communicable Diseases/diagnosis , Communicable Diseases/epidemiology , Communicable Disease Control/methods , Public Health Surveillance/methods , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/prevention & control , Pandemics
4.
JMIR Public Health Surveill ; 10: e47154, 2024 May 24.
Article in English | MEDLINE | ID: mdl-38788212

ABSTRACT

BACKGROUND: The COVID-19 pandemic has prompted the deployment of digital technologies for public health surveillance globally. The rapid development and use of these technologies have curtailed opportunities to fully consider their potential impacts (eg, for human rights, civil liberties, privacy, and marginalization of vulnerable groups). OBJECTIVE: We conducted a scoping review of peer-reviewed and gray literature to identify the types and applications of digital technologies used for surveillance during the COVID-19 pandemic and the predicted and witnessed consequences of digital surveillance. METHODS: Our methodology was informed by the 5-stage methodological framework to guide scoping reviews: identifying the research question; identifying relevant studies; study selection; charting the data; and collating, summarizing, and reporting the findings. We conducted a search of peer-reviewed and gray literature published between December 1, 2019, and December 31, 2020. We focused on the first year of the pandemic to provide a snapshot of the questions, concerns, findings, and discussions emerging from peer-reviewed and gray literature during this pivotal first year of the pandemic. Our review followed the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) reporting guidelines. RESULTS: We reviewed a total of 147 peer-reviewed and 79 gray literature publications. Based on our analysis of these publications, we identified a total of 90 countries and regions where digital technologies were used for public health surveillance during the COVID-19 pandemic. Some of the most frequently used technologies included mobile phone apps, location-tracking technologies, drones, temperature-scanning technologies, and wearable devices. We also found that the literature raised concerns regarding the implications of digital surveillance in relation to data security and privacy, function creep and mission creep, private sector involvement in surveillance, human rights, civil liberties, and impacts on marginalized groups. Finally, we identified recommendations for ethical digital technology design and use, including proportionality, transparency, purpose limitation, protecting privacy and security, and accountability. CONCLUSIONS: A wide range of digital technologies was used worldwide to support public health surveillance during the COVID-19 pandemic. The findings of our analysis highlight the importance of considering short- and long-term consequences of digital surveillance not only during the COVID-19 pandemic but also for future public health crises. These findings also demonstrate the ways in which digital surveillance has rendered visible the shifting and blurred boundaries between public health surveillance and other forms of surveillance, particularly given the ubiquitous nature of digital surveillance. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-https://doi.org/10.1136/bmjopen-2021-053962.


Subject(s)
COVID-19 , Digital Technology , Pandemics , COVID-19/epidemiology , COVID-19/prevention & control , Humans , Pandemics/prevention & control , Public Health Surveillance/methods
6.
Curr Opin Psychiatry ; 37(4): 270-276, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38587019

ABSTRACT

PURPOSE OF REVIEW: New psychoactive substances (NPS) continue to emerge globally and present a threat to public health. This article summarizes the most recent literature on approaches for monitoring NPS use and adverse events related to use. RECENT FINDINGS: A variety of approaches have recently been employed for surveillance of NPS use and associated harms, including the use of toxicology testing of patients in emergency departments, surveys of sentinel populations, drug checking and syringe services programs, wastewater-based epidemiology, and retrospective analyses of clinical samples and toxicology reports. These studies cover a range of time periods and NPS examined across numerous countries. SUMMARY: Areas of particular interest for future research include the use of data from drug checking services to inform surveillance efforts of the illicit drug supply and the development of methods for wastewater-based monitoring of NPS. Studies that combine self-report data with toxicology testing in particular are important for capturing unintentional or unknown exposure to NPS including fentanyls and drugs like xylazine. Given the limitations associated with individual indicators of drug use and associated harms, the harmonization of multiple data sources can help present a more complete picture of both trends involving NPS to better inform public health responses.


Subject(s)
Illicit Drugs , Psychotropic Drugs , Public Health Surveillance , Humans , Psychotropic Drugs/adverse effects , Public Health Surveillance/methods , Illicit Drugs/adverse effects , Substance-Related Disorders/epidemiology , Substance Abuse Detection/methods
7.
Lima; Organización Panamericana de la Salud; 1 ed; Abr. 2024. 229 p. ilus.
Monography in Spanish | MINSAPERÚ, LIPECS | ID: biblio-1551326

ABSTRACT

El presente documento ofrece una herramienta robusta que consta de 79 indicadores, basados en los principios de una atención primaria de salud renovada, y diseñados para ser implementados en los servicios farmacéuticos de la Región. En estas páginas se resume el proceso de desarrollo de estos indicadores, iniciado en el 2019 bajo la dirección y coordinación de la Organización Panamericana de la Salud, con aportes del grupo expertos en el tema, talleres regionales y una prueba piloto en Argentina y Perú en el 2022. Asimismo, se describe el enfoque simplificado de niveles de implementación, que facilita la compresión de los resultados de los indicadores y la toma de decisiones, y además, se incluyen algunos elementos clave para que los países los tengan en cuenta en el momento de implementar esta herramienta. Cada indicador se presenta en su correspondiente ficha técnica, que incluye los elementos configurativos, la clasificación según el grado de complejidad y el ámbito de los servicios farmacéuticos. Esto destaca la importancia de redefinir y evaluar la calidad de los servicios farmacéuticos en todos los niveles de atención de salud.


Subject(s)
Innovation and Development Policy , Public Health Surveillance , Access to Essential Medicines and Health Technologies , Evidence-Based Pharmacy Practice
8.
BMJ Open ; 14(4): e079776, 2024 Apr 05.
Article in English | MEDLINE | ID: mdl-38582533

ABSTRACT

BACKGROUND: The last 3 years have witnessed global health challenges, ranging from the pandemics of COVID-19 and mpox (monkeypox) to the Ebola epidemic in Uganda. Public health surveillance is critical for preventing these outbreaks, yet surveillance systems in resource-constrained contexts struggle to provide timely disease reporting. Although community health workers (CHWs) support health systems in low-income and middle-income countries (LMICs), very little has been written about their role in supporting public health surveillance. This review identified the roles, impacts and challenges CHWs face in public health surveillance in 25 LMICs. METHODS: We conducted a scoping review guided by Arksey and O'Malley's framework. We exported 1,156 peer-reviewed records from Embase, Global Health and PubMed databases. After multiple screenings, 29 articles were included in the final review. RESULTS: CHWs significantly contribute to public health surveillance in LMICs including through contact tracing and patient visitation to control major infectious diseases such as HIV/AIDS, malaria, tuberculosis, Ebola, neglected tropical diseases and COVID-19. Their public health surveillance roles typically fall into four main categories including community engagement; data gathering; screening, testing and treating; and health education and promotion. The use of CHWs in public health surveillance in LMICs has been impactful and often involves incorporation of various technologies leading to improved epidemic control and disease reporting. Nonetheless, use of CHWs can come with four main challenges including lack of education and training, lack of financial and other resources, logistical and infrastructural challenges as well as community engagement challenges. CONCLUSION: CHWs are important stakeholders in surveillance because they are closer to communities than other healthcare workers. Further integration and training of CHWs in public health surveillance would improve public health surveillance because CHWs can provide health data on 'hard-to-reach' populations. CHWs' work in public health surveillance would also be greatly enhanced by infrastructural investments.


Subject(s)
COVID-19 , Hemorrhagic Fever, Ebola , Humans , Developing Countries , Community Health Workers/education , Hemorrhagic Fever, Ebola/epidemiology , Hemorrhagic Fever, Ebola/prevention & control , Public Health Surveillance , COVID-19/epidemiology , COVID-19/prevention & control
9.
BMC Public Health ; 24(1): 1150, 2024 Apr 24.
Article in English | MEDLINE | ID: mdl-38658902

ABSTRACT

BACKGROUND: The Democratic Republic of the Congo (DRC) experienced its largest Ebola Virus Disease Outbreak in 2018-2020. As a result of the outbreak, significant funding and international support were provided to Eastern DRC to improve disease surveillance. The Integrated Disease Surveillance and Response (IDSR) strategy has been used in the DRC as a framework to strengthen public health surveillance, and full implementation could be critical as the DRC continues to face threats of various epidemic-prone diseases. In 2021, the DRC initiated an IDSR assessment in North Kivu province to assess the capabilities of the public health system to detect and respond to new public health threats. METHODS: The study utilized a mixed-methods design consisting of quantitative and qualitative methods. Quantitative assessment of the performance in IDSR core functions was conducted at multiple levels of the tiered health system through a standardized questionnaire and analysis of health data. Qualitative data were also collected through observations, focus groups and open-ended questions. Data were collected at the North Kivu provincial public health office, five health zones, 66 healthcare facilities, and from community health workers in 15 health areas. RESULTS: Thirty-six percent of health facilities had no case definition documents and 53% had no blank case reporting forms, limiting identification and reporting. Data completeness and timeliness among health facilities were 53% and 75% overall but varied widely by health zone. While these indicators seemingly improved at the health zone level at 100% and 97% respectively, the health facility data feeding into the reporting structure were inconsistent. The use of electronic Integrated Disease Surveillance and Response is not widely implemented. Rapid response teams were generally available, but functionality was low with lack of guidance documents and long response times. CONCLUSION: Support is needed at the lower levels of the public health system and to address specific zones with low performance. Limitations in materials, resources for communication and transportation, and workforce training continue to be challenges. This assessment highlights the need to move from outbreak-focused support and funding to building systems that can improve the long-term functionality of the routine disease surveillance system.


Subject(s)
Disease Outbreaks , Hemorrhagic Fever, Ebola , Humans , Democratic Republic of the Congo/epidemiology , Hemorrhagic Fever, Ebola/epidemiology , Hemorrhagic Fever, Ebola/prevention & control , Disease Outbreaks/prevention & control , Public Health Surveillance/methods , Population Surveillance/methods
10.
Ann Epidemiol ; 94: 64-71, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38677568

ABSTRACT

OBJECTIVES: As crises of drug-related maternal harms escalate, US public health surveillance capacity remains suboptimal for drug-related maternal morbidities. Most state hospital discharge databases (HDDs) are encounter-based, and thus limit ascertainment of morbidities to delivery visits and ignoring those occurring during the 21 months spanning pregnancy and postpartum year. This study analyzes data from a state that curates person-centered HDD to compare patterns of substance use disorder (SUD) diagnoses at delivery vs. the full 21 pregnancy/postpartum months, overall and by maternal social position. METHODS: Among people who experienced an in-hospital birth in New York State between 9/1/2016 and 1/1/2018 (N = 330,872), we estimated SUD diagnosis (e.g., opioids, stimulants, benzodiazepines, cannabis) prevalence at delivery; across the full 9 months of pregnancy and 12 postpartum months; and by trimester and postpartum quarter. Risk ratio and risk difference estimated disparities by race/ethnicity, age, rurality, and payor. RESULTS: The 21-month SUD prevalence rate per 100,000 was 2671 (95% CI 2616-2726), with 31% (29.5%-31.5%) missing SUD indication when ascertained at delivery only (1866; 95% CI 1820-1912). Quarterly rates followed a roughly J-shaped trajectory. Structurally marginalized individuals suffered the highest 21-month SUD prevalence (e.g., Black:White risk ratio=1.80 [CI:1.73-1.88]). CONCLUSION: By spanning the full 21 months of pregnancy/postpartum, person-centered HDD reveal than the maternal SUD crisis is far greater than encounter-based delivery estimates had revealed. Generating person-centered HDD will improve efforts to tailor interventions to help people who use drugs survive while pregnant and postpartum, and eliminate inequities.


Subject(s)
Drug Overdose , Patient Discharge , Pregnancy Complications , Substance-Related Disorders , Humans , Female , Pregnancy , Substance-Related Disorders/epidemiology , Adult , Drug Overdose/epidemiology , Patient Discharge/statistics & numerical data , Pregnancy Complications/epidemiology , New York/epidemiology , Young Adult , Public Health Surveillance/methods , Prevalence , Adolescent , Postpartum Period
11.
Public Health ; 231: 71-79, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38636279

ABSTRACT

OBJECTIVES: Public health surveillance systems are critical for detecting and responding to health threats. This review aims to analyze international literature on the performance of these systems in terms of core, support, and attributes of surveillance system. STUDY DESIGN: Systematic review. METHODS: Following the preregistered protocol (PROSPERO: CRD42022366051), a systematic search was conducted on PubMed/MEDLINE, CINHAL, CABI, Web of Science, and Google Scholar for articles evaluating Public Health Surveillance System performance from inception to July 21, 2023. Various study designs were included, and quality assessment was performed. Thematic analysis categorized findings into key surveillance system functions. RESULTS: Nine studies from different countries assessed core and supportive functions, as well as surveillance attributes. Performance varied among countries, with some excelling overall and others showing poor performance in specific areas. Many countries' surveillance systems had inadequate performance in key measures in terms of the core and supportive functions, as well as the attributes of the surveillance system. CONCLUSION: This review shows significant variations in the performance of public health surveillance systems across countries. Further research is needed to understand underperformance reasons and inform global policymaking for strengthening surveillance systems.


Subject(s)
Global Health , Public Health Surveillance , Humans , Public Health Surveillance/methods
12.
Public Health ; 231: 31-38, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38603977

ABSTRACT

OBJECTIVES: Currently, there is no comprehensive picture of the global surveillance landscape. This survey examines the current state of surveillance systems, levels of integration, barriers and opportunities for the integration of surveillance systems at the country level, and the role of national public health institutes (NPHIs). STUDY DESIGN: This was a cross-sectional survey of NPHIs. METHODS: A web-based survey questionnaire was disseminated to 110 NPHIs in 95 countries between July and August 2022. Data were descriptively analysed, stratified by World Health Organization region, World Bank Income Group, and self-reported Integrated Disease Surveillance (IDS) maturity status. RESULTS: Sixty-five NPHIs responded. Systems exist to monitor notifiable diseases and vaccination coverage, but less so for private, pharmaceutical, and food safety sectors. While Ministries of Health usually lead surveillance, in many countries, NPHIs are also involved. Most countries report having partially developed IDS. Surveillance data are frequently inaccessible to the lead public health agency and seldomly integrated into a national public health surveillance system. Common challenges to establishing IDS include information technology system issues, financial constraints, data sharing and ownership limitations, workforce capacity gaps, and data availability. CONCLUSIONS: Public health surveillance systems across the globe, although built on similar principles, are at different levels of maturity but face similar developmental challenges. Leadership, ownership and governance, supporting legal mandates and regulations, as well as adherence to mandates, and enforcement of regulations are critical components of effective surveillance. In many countries, NPHIs play a significant role in integrated disease surveillance.


Subject(s)
Global Health , Humans , Cross-Sectional Studies , Global Health/statistics & numerical data , Surveys and Questionnaires , Public Health Surveillance/methods , Systems Integration
13.
Copenhagen and Stockholm; World Health Organization. Regional Office for Europe. European Centre for Disease Prevention and Control; 2024-03-20.
in English | WHO IRIS | ID: who-376305

ABSTRACT

This report provides an overview of the latest tuberculosis (TB) epidemiological situation and is published jointly by the WHO Regional Office for Europe and the European Centre for Disease Prevention and Control. In 2022, a little over 170 000 incident TB cases were notified in countries of the WHO European Region, a slight increase from 2021. The increase in 2022 is likely due to a good recovery after the COVID-19 pandemic in access to and provision of TB services in many countries and the introduction of active TB case-finding activities. Despite the notable progress achieved in the fight against TB, countries still face various challenges in reaching the goal of ending the TB epidemic in the WHO European Region. Monitoring progress towards the targets of the new Tuberculosis action plan for the WHO European Region 2023–2030 is difficult due to limited or no reporting on some indicators. Further improvement of data completeness and representativeness should be the focus for all countries.


Subject(s)
Tuberculosis , Public Health Surveillance , Epidemiological Monitoring , Data Collection , Europe
14.
Rev. bioét. derecho ; (60): 53-74, Mar. 2024.
Article in Portuguese | IBECS | ID: ibc-230472

ABSTRACT

O presente artigo discute os avanços e desafios das tecnologias de monitoramento em saúde de pessoas idosas e suas implicações na privacidade e confidencialidade dos dados coletados. Trata-se de estudo exploratório, fundamentado na literatura, com síntese narrativa. O texto contextualiza as demandas decorrentes do envelhecimento populacional e o uso de sensores e de outros dispositivos eletrônicos no monitoramento de atividades diárias de pessoas idosas em ambientes internos e externos. É importante ressaltar que os benefícios oferecidos pelas tecnologias não devem comprometer a privacidade e a confidencialidade dos dados. Para garantir isso, é necessário aprimorar os mecanismos regulatórios, estabelecendo padrões de segurança e princípios éticos para a proteção de dados pessoais, respeitando a privacidade e a confidencialidade dos dados.(AU)


L'article present discuteix els avenços i reptes de les tecnologies de monitoratge en salut de les persones majors i les seves implicacions en la privacitat i confidencialitat de les dades recopilades. Es tracta d'un estudi exploratori, fonamentat en la literatura, amb una síntesi narrativa. El text contextualitza les demandes derivades de l'envelliment de la població i l'ús de sensors i d'altres dispositius electrònics en el monitoratge de les activitats quotidianes de les persones majors en ambients interns i externs. És important destacar que els beneficis oferts per les tecnologies no han de comprometre la privacitat i la confidencialitat de les dades. Per garantir-ho, és necessari millorar els mecanismes reguladors, establint estàndards de seguretat i principis ètics pera la protecció de dades personals, respectant la privacitat i la confidencialitat de les dades.(AU)


El presente artículo discute los avances y desafíos de las tecnologías de monitorización en salud de personas mayores y sus implicaciones en la privacidad y confidencialidad de los datos recolectados. Se trata de un estudio exploratorio, fundamentado en la literatura, con síntesis narrativa. El texto contextualiza las demandas derivadas del envejecimiento poblacional y el uso de sensores y otros dispositivos electrónicos en la monitorización de actividades diarias de personas mayores en ambientes internos y externos. Es importante resaltar que los beneficios ofrecidos por las tecnologías no deben comprometer la privacidad y confidencialidad de los datos. Para garantizar esto, es necesario mejorar los mecanismos reguladores, estableciendo estándares de seguridad y principios éticos para la protección de datos personales, respetando la privacidad y confidencialidad de los dato.(AU)


This article discusses the advances and challenges of health monitoring technologies for elderly individuals and their implications on the privacy and confidentiality of collected data. It is an exploratory study grounded in the literature, with a narrative synthesis. The text contextualizes the demands arising from the aging population and the use of sensors and other electronic devices in monitoring daily activities of elderly people in both indoor and outdoor environments. It is important to emphasize that the benefits offered by these technologies should not compromise the privacy and confidentiality of the data. To ensure this, it is necessary to enhance regulatory mechanisms by establishing security standards and ethical principles for the protection of personal data, while respecting privacy and data confidentiality.(AU)


Subject(s)
Humans , Male , Female , Aged , Public Health Surveillance , Confidentiality , Information Technology , Telemedicine , Bioethics
15.
Washington, D.C.; OPS; 2024-03-08.
in Spanish | PAHO-IRIS | ID: phr-59342

ABSTRACT

Este documento ofrece una herramienta robusta que consta de 79 indicadores, basados en los principios de una atención primaria de salud renovada, y diseñados para ser implementados en los servicios farmacéuticos de la Región. En estas páginas se resume el proceso de desarrollo de estos indicadores, iniciado en el 2019 bajo la dirección y coordinación de la Organización Panamericana de la Salud, con aportes del grupo expertos en el tema, talleres regionales y una prueba piloto en Argentina y Perú en el 2022. Asimismo, se describe el enfoque simplificado de niveles de implementación, que facilita la compresión de los resultados de los indicadores y la toma de decisiones, y además, se incluyen algunos elementos clave para que los países los tengan en cuenta en el momento de implementar esta herramienta. Cada indicador se presenta en su correspondiente ficha técnica, que incluye los elementos configurativos, la clasificación según el grado de complejidad y el ámbito de los servicios farmacéuticos. Esto destaca la importancia de redefinir y evaluar la calidad de los servicios farmacéuticos en todos los niveles de atención de salud. Este instrumento será útil para las autoridades sanitarias, al permitir la adaptación según las capacidades y objetivos de cada país. Servirá además como recurso de autoevaluación para los servicios farmacéuticos, al facilitar la formulación de planes de mejora continua. El público destinatario incluye a las autoridades sanitarias, asociaciones y colegios de profesionales farmacéuticos, la academia y todas las personas involucradas en la gestión y seguimiento de la atención de los servicios farmacéuticos.


Subject(s)
Access to Essential Medicines and Health Technologies , Public Health Surveillance , Innovation and Development Policy , Evidence-Based Pharmacy Practice
16.
Article in English | PAHO-IRIS | ID: phr-59318

ABSTRACT

[ABSTRACT]. This article points out deficiencies in present-day definitions of public health surveillance, which include data collection, analysis, interpretation and dissemination, but not public health action. Controlling a public health problem of concern requires a public health response that goes beyond information dissemination. It is unde- sirable to have public health divided into data generation processes (public health surveillance) and data use processes (public health response), managed by two separate groups (surveillance experts and policy-makers). It is time to rethink the need to modernize the definition of public health surveillance, inspired by the authors’ enhanced Data, Information, Knowledge, Intelligence and Wisdom model. Our recommendations include expanding the scope of public health surveillance beyond information dissemination to comprise actionable knowledge (intelligence); mandating surveillance experts to assist policy-makers in making evidence-informed decisions; encouraging surveillance experts to become policy-makers; and incorporating public health literacy training – from data to knowledge to wisdom – into the curricula for all public health professionals. Work on modernizing the scope and definition of public health surveillance will be a good starting point.


[RESUMEN]. En este artículo se señalan las deficiencias de las definiciones actuales de la vigilancia de salud pública, que incluyen la recopilación, el análisis, la interpretación y la difusión de los datos, pero no las medidas de salud pública. El control de un problema de salud pública de interés exige una respuesta de salud pública que vaya más allá de la difusión de información. No es deseable que la salud pública esté dividida por un lado en procesos de generación de datos (vigilancia de salud pública) y por otro en procesos de uso de datos (respuesta de salud pública), gestionados por dos grupos diferentes (expertos en vigilancia y responsables de la formulación de políticas). Ha llegado el momento de replantear la necesidad de modernizar la definición de la vigilancia de salud pública tomando como referencia el modelo mejorado de Datos, Información, Cono- cimiento, Inteligencia y Sabiduría de los autores. Entre las recomendaciones que se proponen se encuentran las de ampliar el alcance de la vigilancia de salud pública más allá de la difusión de información para que incluya también el conocimiento aplicable (inteligencia); instar a los expertos en vigilancia a que presten ayuda a los responsables de la formulación de políticas en la toma de decisiones basadas en la evidencia; alentar a los expertos en vigilancia a que se conviertan en responsables de la formulación de políticas; e incorporar la formación en conocimientos básicos de salud pública (desde los datos hasta los conocimientos y la sabiduría) en los planes de estudio de todos los profesionales de la salud pública. Un buen punto de partida será trabajar en la modernización del alcance y la definición de la vigilancia de salud pública.


[RESUMO]. Este artigo aponta deficiências nas definições atuais de vigilância em saúde pública, que incluem coleta, análise, interpretação e disseminação de dados, mas não ações de saúde pública. O controle de um prob- lema preocupante de saúde pública exige uma resposta de saúde pública que vá além da disseminação de informações. A saúde pública não deve ser dividida em processos de geração de dados (vigilância em saúde pública) e processos de uso de dados (resposta de saúde pública) gerenciados por dois grupos distintos (especialistas em vigilância e formuladores de políticas). É hora de repensar a necessidade de modernizar a definição de vigilância em saúde pública, inspirada no modelo aprimorado de Dados, Informações, Con- hecimento, Inteligência e Sabedoria dos autores. Nossas recomendações incluem: expansão do escopo da vigilância em saúde pública para além da disseminação de informações, de modo a abranger conhecimentos acionáveis (inteligência); obrigatoriedade de que os especialistas em vigilância auxiliem os formuladores de políticas na tomada de decisões baseadas em evidências; incentivo para que os especialistas em vigilân- cia se tornem formuladores de políticas; e incorporação de capacitação em letramento em saúde pública (partindo dos dados para o conhecimento e em seguida para a sabedoria) nos currículos de todos os profis- sionais de saúde pública. O trabalho de modernizar o escopo e a definição de vigilância em saúde pública será um bom ponto de partida.


Subject(s)
Public Health Surveillance , Data Collection , Health Information Management , Population Health Management , Health Literacy , Learning Health System , Intelligence , Public Health Surveillance , Data Collection , Health Information Management , Population Health Management , Health Literacy , Learning Health System , Intelligence , Public Health Surveillance , Data Collection , Health Information Management , Population Health Management , Health Literacy , Learning Health System , Intelligence
17.
Brasília, D.F.; OPAS; 2024-03-05. (OPAS/BRA_MS/23-0011).
Non-conventional in Portuguese | PAHO-IRIS | ID: phr2-59329

ABSTRACT

A Vigilância em Saúde desempenha papel estratégico já que pressupõe o acompanhamento e análise permanentes da situação de saúde da população visando, direcionar ações para controlar determinantes, riscos e danos à saúde da população, garantindo-se a integralidade da atenção individual e coletiva dos problemas de saúde. Abrange a Vigilância Epidemiológica das doenças transmissíveis e não transmissíveis, a Vigilância em Saúde Ambiental em Saúde e a Vigilância em Saúde do Trabalhador. A Política Nacional de Vigilância em Saúde (PNVS), instituída em 2018 por meio da Resolução CNS nº 588, norteia o planejamento das ações de vigilância em saúde nas três esferas de gestão do SUS, caracterizado pela definição das responsabilidades, princípios, diretrizes e estratégias dessa vigilância. A importância desse tema tornou o processo de gestão em Vigilância em Saúde ainda mais aprimorado e eficiente, com o alcance dos objetivos e uso racional de recursos, aprimorando a relação custo-efetividade das ações, programas e políticas. A finalidade e objetivos do TC 75 foram alinhados ao plano estratégico de cooperação técnica da OPAS/OMS e com os Objetivos de Desenvolvimento do Milênio (ODM).


Subject(s)
Public Health Surveillance , Epidemiological Monitoring , Communicable Diseases , Noncommunicable Diseases , Environmental Health Surveillance , Surveillance of the Workers Health , Unified Health System , Technical Cooperation , Brazil
18.
JMIR Infodemiology ; 4: e54000, 2024 Mar 08.
Article in English | MEDLINE | ID: mdl-38457224

ABSTRACT

Despite challenges related to the data quality, representativeness, and accuracy of artificial intelligence-driven tools, commercially available social listening platforms have many of the attributes needed to be used for digital public health surveillance of human papillomavirus vaccination misinformation in the online ecosystem.


Subject(s)
Papillomavirus Infections , Papillomavirus Vaccines , Humans , Artificial Intelligence , Communication , Papillomavirus Infections/prevention & control , Public Health Surveillance
19.
Rev. esp. salud pública ; 98: e202402002, Feb. 2024. tab, graf
Article in Spanish | IBECS | ID: ibc-231345

ABSTRACT

Fundamentos: Durante la pandemia de la COVID-19 se implementaron medidas de prevención con el propósito de reducir su transmisión comunitaria. El grado de cumplimiento con estas medidas estuvo influenciado por diversos factores sociodemográficos y ambientales. Sin embargo, existe escasa literatura científica que aborde el cumplimiento de las medidas preventivas en la población general. El objetivo de este estudio fue analizar la asociación entre factores sociodemográficos y ambientales, así como la adhesión al uso de mascarillas en contactos estrechos. Métodos: Se realizó un estudio transversal con 1.778 individuos, identificados mediante el rastreo de contactos estrechos de personas con SARS-CoV-2 por la Central de Coordinación de la COVID-19 de Mallorca, entre febrero y junio de 2021. Se realizó un análisis descriptivo y se utilizó un modelo de regresión logística para determinar los factores asociados al incumplimiento del uso de mascarillas.Resultados: La edad media de los participantes fue de 42,8±17,4 años (53,6% de mujeres). El 60,8% (IC 95%: 57,8-62,3) de los contactos estrechos no utilizó mascarilla durante su contacto. No se observaron diferencias estadísticamente significativas en función del sexo o grupo etario (p=0,497 y p=0,536, respectivamente). Las situaciones de mayor incumplimiento con el uso de mascarillas se dieron en el entorno domiciliario, espacios cerrados sin ventilación y al mantener distancias cortas (p<0,001). Conclusiones: Nuestros hallazgos indican una menor adhesión al uso de mascarillas en escenarios de mayor riesgo. Frente a futuras situaciones de crisis sanitaria, se deberían diseñar intervenciones que realcen la conciencia sobre los riesgos y que promuevan una mayor adhesión a medidas de prevención y control.(AU)


Background: During COVID-19 pandemic, prevention measures were implemented to mitigate the community transmission of SARS-CoV-2. Compliance with these measures was influenced by several sociodemographic and environmental factors. However, literature addressing compliance with these prevention measures among the general population remains limited. The study aimed to assess the association of sociodemographic and environmental factors and mask usage during close contact situations. Methods: A cross-sectional study was conducted with a sample of 1,778 individuals identified through close contact tracing of indivi-duals diagnosed with SARS-CoV-2 by the COVID-19 Coordination Center of Mallorca, from February to June 2021. A descriptive analysis was conducted, and a logistic regression model was utilized to evaluate factors associated with mask non-compliance. Results: The mean age of the participants was 42.8±17.4 years, with 53.6% being female. Among close contacts, 60.8% (95% CI: 57.8-62.3) did not use masks during their contact. No significant differences were observed between genders or across age groups (p=0.497 and p=0.536, respectively). Factors linked to mask non-compliance included the home setting, indoor spaces without venti-lation, and closer physical distances (p<0.001). Conclusions: Our findings indicate that mask adherence was notably lower among close contacts exposed to higher risk. In future public health crises, interventions should be developed to raise awareness about risks and promote adherence to preventive and control measures.(AU)


Subject(s)
Humans , Male , Female , Adult , Masks , Personal Protection , /prevention & control , Respiratory Tract Diseases/prevention & control , Disease Prevention , Public Health , /epidemiology , Public Health Surveillance , Spain , Cross-Sectional Studies
20.
BMC Public Health ; 24(1): 392, 2024 02 06.
Article in English | MEDLINE | ID: mdl-38321469

ABSTRACT

BACKGROUND: Public Health Dashboards (PHDs) facilitate the monitoring and prediction of disease outbreaks by continuously monitoring the health status of the community. This study aimed to identify design principles and determinants for developing public health surveillance dashboards. METHODOLOGY: This scoping review is based on Arksey and O'Malley's framework as included in JBI guidance. Four databases were used to review and present the proposed principles of designing PHDs: IEEE, PubMed, Web of Science, and Scopus. We considered articles published between January 1, 2010 and November 30, 2022. The final search of articles was done on November 30, 2022. Only articles in the English language were included. Qualitative synthesis and trend analysis were conducted. RESULTS: Findings from sixty-seven articles out of 543 retrieved articles, which were eligible for analysis, indicate that most of the dashboards designed from 2020 onwards were at the national level for managing and monitoring COVID-19. Design principles for the public health dashboard were presented in five groups, i.e., considering aim and target users, appropriate content, interface, data analysis and presentation types, and infrastructure. CONCLUSION: Effective and efficient use of dashboards in public health surveillance requires implementing design principles to improve the functionality of these systems in monitoring and decision-making. Considering user requirements, developing a robust infrastructure for improving data accessibility, developing, and applying Key Performance Indicators (KPIs) for data processing and reporting purposes, and designing interactive and intuitive interfaces are key for successful design and development.


Subject(s)
COVID-19 , Public Health Surveillance , Humans , Dashboard Systems , Data Analysis , Databases, Factual
SELECTION OF CITATIONS
SEARCH DETAIL
...